Cite
HARVARD Citation
Schiff, M. et al. (2013). AB0323 Weekly subcutaneous abatacept confers comparable onset of treatment response and magnitude of efficacy improvement over 6 months when administered with or without an intravenous abatacept loading dose. Annals of the rheumatic diseases. p. A886. [Online].